BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn

Transfus Med. 2014 Feb;24(1):8-20. doi: 10.1111/tme.12091.
No abstract available

Publication types

  • Practice Guideline

MeSH terms

  • Erythroblastosis, Fetal / blood
  • Erythroblastosis, Fetal / epidemiology
  • Erythroblastosis, Fetal / prevention & control*
  • Female
  • Humans
  • Immunologic Factors / administration & dosage*
  • Infant, Newborn
  • Male
  • Pregnancy
  • Pregnancy Trimester, Third*
  • Rh-Hr Blood-Group System / blood
  • Rho(D) Immune Globulin / administration & dosage*

Substances

  • Immunologic Factors
  • Rh-Hr Blood-Group System
  • Rho(D) Immune Globulin
  • Rho(D) antigen